ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,449.72
0.42%
US Tech 100
18,555.20
0.11%
Dow Jones
40,201.71
0.87%
Brent Oil
81.515
0.97%
Bitcoin
64,900.35
-0.71%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Poolbeg Pharma Plc (POLB) Quote

Poolbeg Pharma Plc

Poolbeg Pharma Plc (POLB)

LSE
12.65
-0.40
(-3.07%)
Closed July 25 11:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
12.65
Bid
12.50
Ask
12.80
Volume
826,584
12.65 Day's Range 13.05
6.55 52 Week Range 15.70
Market Cap
63.25M
Previous Close
13.05
Open
13.05
Last Trade
10000
@
12.7
(O)
Last Trade Time
Financial Volume
107,043p
VWAP
12.95
Average Volume (3m)
1,779,517
Shares Outstanding
500,000,000
Dividend Yield
-
PE Ratio
-16.01
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-3.93M

About Poolbeg Pharma Plc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.poolbegpharma.com
Headquarters
London, Gbr
Founded
1970
Poolbeg Pharma Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker POLB. The last closing price for Poolbeg Pharma was 13.05p. Over the last year, Poolbeg Pharma shares have traded in a share price range of 6.55p to 15.70p.

Poolbeg Pharma currently has 500,000,000 shares outstanding. The market capitalization of Poolbeg Pharma is £65.25 million. Poolbeg Pharma has a price to earnings ratio (PE ratio) of -16.01.

POLB Latest News

More News

Poolbeg Pharma PLC Notification of Major Holdings

Poolbeg Pharma PLC 10 July 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

July 10 2024
RNS Regulatory News

Poolbeg Pharma PLC Change of Registered Address

Poolbeg Pharma PLC 02 July 2024   Poolbeg Pharma plc   Change of Registered Address   2 July 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, 'Poolbeg' or the 'Company'), a biopharmaceutical...

July 02 2024
RNS Regulatory News

Poolbeg Pharma PLC Result of AGM

Poolbeg Pharma PLC 17 June 2024   Poolbeg Pharma plc    Results of Annual General Meeting 13 June 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, 'Poolbeg' or the 'Company'), a...

June 17 2024
RNS Regulatory News

Poolbeg Pharma PLC Annual Report & AGM Notice

Poolbeg Pharma PLC 09 May 2024   Poolbeg Pharma plc    Annual Report & AGM Notice  9 May 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, 'Poolbeg' or the 'Company'), a biopharmaceutical...

May 09 2024
RNS Regulatory News

Poolbeg Pharma celebrates full patent approval for Immunomodulator II

Poolbeg Pharma PLC on Wednesday said that it has received a fully granted patent from the US Patent Office for its Im ...

May 01 2024
Alliance News

Poolbeg Pharma PLC Significant POLB 001 Patent Granted in USA

Poolbeg Pharma PLC 01 May 2024   Poolbeg Pharma plc    Significant POLB 001 Patent Granted in United States   Immunomodulator II patent grant further strengthens robust intellectual property...

May 01 2024
RNS Regulatory News

EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down

The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by ...

April 30 2024
Alliance News

Poolbeg Pharma PLC Appointment of Joint Broker

Poolbeg Pharma PLC 30 April 2024   Poolbeg Pharma plc   Appointment of Joint Broker   30 April 2024 - Poolbeg Pharma Plc (AIM: POLB, OTCQB: POLBF, 'Poolbeg' or the 'Company'), a...

April 30 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.55-4.1666666666713.213.212.6122876012.9002478DE
4-0.1-0.7843137254912.7513.912.6182271913.34931147DE
12-0.15-1.17187512.815.712.05177951713.47011372DE
264.453.33333333338.2515.78.25196300811.53357538DE
525.372.10884353747.3515.76.55158524410.30256513DE
1561.77516.321839080510.87515.74.113187168.88068503DE
2601.65151115.74.113423748.92469996DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
POAIPredictive Oncology Inc
$ 1.78
(66.36%)
152.95M
PBMPsyence Biomedical Ltd
$ 0.6126
(56.52%)
78.56M
SLRXSalarius Pharmaceuticals Inc
$ 3.23
(50.93%)
29.26M
CMAXCareMax Inc
$ 5.6995
(46.89%)
20.09M
NVNINVNI Group Ltd
$ 1.67
(38.02%)
153.67k
TWOU2U Inc
$ 1.54
(-62.62%)
4.82M
EZFLEzFill Holdings Inc
$ 3.75
(-39.76%)
169.67k
CTNTCheetah Net Supply Chain Service Inc
$ 0.320499
(-33.51%)
10.82M
SLGLSol Gel Technologies Ltd
$ 0.448021
(-33.13%)
14.25M
KDLYKindly MD Inc
$ 2.16
(-32.92%)
750.75k
NVDANVIDIA Corporation
$ 114.79
(0.47%)
356.69M
SQQQProShares UltraPro Short QQQ
$ 9.0399
(-0.22%)
205.12M
SLNASelina Hospitality PLC
$ 0.03975
(-13.02%)
167.72M
POAIPredictive Oncology Inc
$ 1.78
(66.36%)
152.95M
PBMPsyence Biomedical Ltd
$ 0.6126
(56.52%)
78.56M

Discussion

View Full Feed
Nebuchadnezzar Nebuchadnezzar 2 minutes ago
all volume at ask

all volume at 0004

all volume painted red

mmmmmmmmmmmmmmmmk
RITE
Tyrus603 Tyrus603 2 minutes ago
So those selling here must be giving up on ever hearing another word from the company again.

Honestly, the thought has crossed my mind too.

As in, what if... they just walk away from the symbol -- The End?

Didn't they drain all the resources out already?
SPOM
1plus1 1plus1 2 minutes ago
WHY I'M I GETTING NASTY PM MESSAGES FROM 2 ALIASES >> DO THEY KNOW WHAT'S ABOUT TO HAPPEN?
HIRU
Carjockey2 Carjockey2 2 minutes ago
Hey listen

That was before Elon Musk owned it. I would try again!!!!!

Lol
HIRU
myjog myjog 2 minutes ago
Someone is deleting my messages.
RDGL
Myth Myth 2 minutes ago
Nice find there buddy !

that vid is new to me, and I've been listening to Buddy for many years....
fink fink 2 minutes ago
Amen.

MITI pharma play was like that for me. A $150m drug pipeline then CEO sold out his 10m shares for $14
It was still a sweet $5 to $14,bump. Us commons are still in a class action that will never be seen in court.

Woodside on the American exchanges??
MITI
JRoon71 JRoon71 2 minutes ago
Good find, Sleven.

The last paragraph was interesting:
This case suggests that, in order to succeed in “skinny label” cases, a generic manufacturer may need to overcome established prescribing practices, which may be influenced not only by the patentee’s label but its market te
AMRN
RMS555 RMS555 3 minutes ago
Anything that is "bad" about the CEO of KEGS is over 10 years old, easily considered old news!

Just look at the progress KEGS has made in the last 1.5 years while a certain few here have been saying scam for that long.

KEGS owns and operates 2 restaurants/bars now wit
KEGS
palaypu0406 palaypu0406 3 minutes ago
RD, please read through the work sheet,
ITUP
Wayne R Wayne R 3 minutes ago
Maybe a 2 for the price of 1 sale soon?
MULN
Golden Cross Golden Cross 3 minutes ago
$NWPN .0002~NEW CEO~ ACQUISITION ~ Things Turning Around Here!!

https://investorshub.advfn.com/uimage/uploads/2024/7/25/hljafnwpn-1.png
NWPN
QuantumTravesty QuantumTravesty 4 minutes ago
Yes the irony was lost on the lib appeals intern. Thanks.
HIRU
RyNo_23 RyNo_23 4 minutes ago
Quiet around here....we are due for an update.


$RWGI
RWGI
nowwhat2 nowwhat2 4 minutes ago
Too bad we are only allowed just one Sticky......


https://investorshub.advfn.com/uimage/uploads/2024/7/25/lyjrpbtc_777_25_capt_1115am_OHTL.jpg


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174809108

https://www.youtube.com
BTCUSD
Carjockey2 Carjockey2 4 minutes ago
Love it

From $HIRU!
IMO (for what its worth) There is nothing ordinary or traditional with the new incoming Qatar in $HIRU. A well run corp entity whose aspirations does not align with the traditional average OTC (Pink Co) deal. (ie:1st ever OTC SPAC deal) Diluting a penny sto
HIRU
hweb2 hweb2 4 minutes ago
Uhhh thanks. I thought we already knew PSIX had exploded higher recently due to AI hype & momo traders.

Not sure why you spend so much time on a stock you already sold. Seems wiser to do that homework before you buy.
ALDRADJKD123 ALDRADJKD123 4 minutes ago
Union Station Monument Defaced “Hamas”,

https://youtu.be/QOAVRMbXTdo?si=GOsfmbEfumFfqNYe
QuicKtip QuicKtip 4 minutes ago
Why Now is the Time to Invest in AI Technology - $CBDW https://cbdw.ai/why-now-is-the-time-to-invest-in-ai-technology/
CBDW
nsomniyak nsomniyak 4 minutes ago
It is not a commercially available product - it seems to be a home chemistry project.
VDRM
Monksdream Monksdream 5 minutes ago
GWAV new 52 week low
https://investorshub.advfn.com/uimage/uploads/2024/7/25/yytqgIMG_9984.gif
GWAV
pepeoil pepeoil 5 minutes ago
hey bruh, I doubled my money on nvda since you were yelling SELL SELL SELL. lol
SHMP
Viewmont Viewmont 5 minutes ago
From $HIRU!
IMO (for what its worth) There is nothing ordinary or traditional with the new incoming Qatar in $HIRU. A well run corp entity whose aspirations does not align with the traditional average OTC (Pink Co) deal. (ie:1st ever OTC SPAC deal) Diluting a penny stock is bellow them!
HIRU
Golden Cross Golden Cross 5 minutes ago
$NWPN .0002~NEW CEO~ ACQUISITION ~ Things Turning Around Here!!

https://investorshub.advfn.com/uimage/uploads/2024/7/25/hljafnwpn-1.png
NWPN

Your Recent History

LSE
POLB
Poolbeg Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved